HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases].

Abstract
Three patients (2 females, 1 male) with a mean age of 51.4 years receiving long term hemodialysis affected by tumoral calcinosis were analysed. Clinical, radiological and pathological features were evaluated and pathogenic were reviewed. The joints involved int the cases presented in this report were the hip shoulder and finger. The lesions were bilateral in shoulder. An increased calcium-phosphorus product (Ca x P) was observed in all patients with secondary hyperparathyroidism in one case. Surgery was carried out in all patients. No relapse of the tumoral calcinosis was observed after surgery. The most important pathogenic factor involved in uremic tumoral calcinosis is an increase in calcium-phosphorus product (Ca x P) not necessarily related to hyperparathyroidism. Therefore, maintaining the calcium x phosphate product within the normal range appears to be the most important factor ito prevent the appearance of uraemic tumoral calcinosis.
AuthorsC Ben Taarit, F el Younsi, S Turki, M Mestiri, M Zlitni, H Ben Maïz
JournalNephrologie (Nephrologie) Vol. 22 Issue 7 Pg. 349-52 ( 2001) ISSN: 0250-4960 [Print] Switzerland
Vernacular TitleLa calcinose tumorale des hémodialysés: étude anatomoclinique: à propos de trois cas.
PMID11817212 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Phosphorus
Topics
  • Adult
  • Calcinosis (etiology, surgery)
  • Chronic Kidney Disease-Mineral and Bone Disorder (etiology)
  • Female
  • Fingers (pathology, surgery)
  • Hip Joint (pathology, surgery)
  • Humans
  • Hypercalcemia (etiology)
  • Hyperparathyroidism, Secondary (etiology)
  • Joint Diseases (etiology, surgery)
  • Kidney Failure, Chronic (blood, complications, therapy)
  • Male
  • Middle Aged
  • Phosphorus (blood)
  • Renal Dialysis (adverse effects)
  • Shoulder Joint (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: